Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 372,700 | 401,500 | 310,900 | 305,800 | 304,300 |
| Marketable Securities | 202,300 | 156,400 | 210,500 | 316,700 | 201,700 |
| Receivables | 341,800 | 329,700 | 347,500 | 325,400 | 336,400 |
| Inventories | 299,500 | 288,500 | 281,000 | 286,000 | 265,400 |
| Income taxes - deferred | 33,900 | 34,900 | 43,400 | 42,400 | 36,000 |
| Other current assets | 97,700 | 106,500 | 57,000 | 69,300 | 95,500 |
| TOTAL | $1,390,600 | $1,360,700 | $1,291,900 | $1,387,700 | $1,278,800 |
| Non-Current Assets | |||||
| PPE Net | 399,200 | 385,400 | 373,300 | 328,700 | 315,800 |
| Investments And Advances | 21,900 | 22,500 | 21,100 | 23,400 | 22,100 |
| Intangibles | 446,100 | 445,700 | 451,700 | 409,400 | 411,500 |
| Other Non-Current Assets | 81,900 | 82,300 | 83,500 | 46,600 | 46,900 |
| TOTAL | $949,100 | $935,900 | $929,600 | $808,100 | $796,300 |
| Total Assets | $2,339,700 | $2,296,600 | $2,221,500 | $2,195,800 | $2,075,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 314,200 | 300,400 | 74,700 | 298,600 | 284,300 |
| Accrued Expenses | N/A | N/A | 272,700 | N/A | N/A |
| TOTAL | $314,200 | $300,400 | $347,400 | $298,600 | $284,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | 227,300 | 192,700 | 189,300 | 175,400 | 185,100 |
| Other Non-Current Liabilities | 218,400 | 211,500 | 205,500 | 185,500 | 171,100 |
| TOTAL | $445,700 | $404,200 | $394,800 | $360,900 | $356,200 |
| Total Liabilities | $759,900 | $704,600 | $742,200 | $659,500 | $640,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 673,636 | 677,771 | 684,604 | 692,466 | 694,283 |
| Common Shares | 125,400 | 124,700 | 124,200 | 123,900 | 123,000 |
| Retained earnings | 1,892,900 | 1,798,800 | 1,653,900 | 1,562,800 | 1,493,600 |
| Other shareholders' equity | -47,600 | -51,700 | -37,800 | -37,200 | -51,000 |
| TOTAL | $1,579,800 | $1,592,000 | $1,479,300 | $1,536,300 | $1,434,600 |
| Total Liabilities And Equity | $2,339,700 | $2,296,600 | $2,221,500 | $2,195,800 | $2,075,100 |